Mar 08, 2021 05:20 PM (GMT+8) · EqualOcean
Baiyunshan announced that Baiyunshan Pharmaceutical General Factory of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (Baiyunshan Pharmaceutical General Factory), a branch of the company, received the approval notice of drug supplement application issued by the State Drug Administration, and amlodipine besylate tablets have passed the quality and efficacy consistency evaluation of generic drugs. Amlodipine besylate is a dihydropyridine calcium antagonist, which is used in the treatment of essential hypertension, chronic stable angina pectoris and variant angina pectoris.